Vitranu

About:

Vitranu develops novel extended administration drug delivery technology.

Description:

Vitranu provides a platform technology to fulfill the unmet need for sustained, controllable ophthalmic drug delivery. They develop a tunable extended-release capsule for biologic pharmaceuticals.

Total Funding Amount:

$1.51M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Columbus, Ohio, United States

Founded Date:

2020-01-01

Contact Email:

jblack(AT)vitranu.com

Founders:

Gordon Bethwaite

Number of Employees:

1-10

Last Funding Date:

2021-10-25

IPO Status:

Private

Industries: